125 related articles for article (PubMed ID: 38072470)
1. Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot.
Beard C; Rogers CA; Fleming L; Conibear J; Evison M; Newsom-Davis T; Barwick T; Mills N; Stokes EA; De Sousa P; Batchelor T; Rawlinson J; Baos S; Harris R; Lim E
BMJ Open; 2023 Dec; 13(12):e081650. PubMed ID: 38072470
[TBL] [Abstract][Full Text] [Related]
2. Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
Conibear J; Chia B; Ngai Y; Bates AT; Counsell N; Patel R; Eaton D; Faivre-Finn C; Fenwick J; Forster M; Hanna GG; Harden S; Mayles P; Moinuddin S; Landau D
BMJ Open; 2018 Apr; 8(4):e020690. PubMed ID: 29666135
[TBL] [Abstract][Full Text] [Related]
3. Study protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study).
Lim E; Batchelor T; Shackcloth M; Dunning J; McGonigle N; Brush T; Dabner L; Harris R; Mckeon HE; Paramasivan S; Elliott D; Stokes EA; Wordsworth S; Blazeby J; Rogers CA;
BMJ Open; 2019 Oct; 9(10):e029507. PubMed ID: 31615795
[TBL] [Abstract][Full Text] [Related]
4. Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT.
Lim E; Harris RA; McKeon HE; Batchelor TJ; Dunning J; Shackcloth M; Anikin V; Naidu B; Belcher E; Loubani M; Zamvar V; Dabner L; Brush T; Stokes EA; Wordsworth S; Paramasivan S; Realpe A; Elliott D; Blazeby J; Rogers CA
Health Technol Assess; 2022 Dec; 26(48):1-162. PubMed ID: 36524582
[TBL] [Abstract][Full Text] [Related]
5. Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study.
Hatton MQF; Lawless CA; Faivre-Finn C; Landau D; Lester JF; Fenwick J; Simões R; McCartney E; Boyd KA; Haswell T; Shaw A; Paul J
BMJ Open; 2019 Jan; 9(1):e019903. PubMed ID: 30700475
[TBL] [Abstract][Full Text] [Related]
6. NAVIGATE: improving survival in vulnerable patients with lung cancer through nurse navigation, symptom monitoring and exercise - study protocol for a multicentre randomised controlled trial.
Langballe R; Dalton SO; Jakobsen E; Karlsen RV; Iachina M; Freund KM; Leclair A; Nielsen AS; Andersen EAW; Rosthøj S; Jørgensen LB; Skou ST; Bidstrup PE
BMJ Open; 2022 Oct; 12(10):e060242. PubMed ID: 36316074
[TBL] [Abstract][Full Text] [Related]
7. Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1-5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial.
Tibdewal A; Agarwal JP; Srinivasan S; Mummudi N; Noronha V; Prabhash K; Patil V; Purandare N; Janu A; Kannan S
BMJ Open; 2021 Mar; 11(3):e043628. PubMed ID: 33727268
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancer.
Tibdewal A; Agarwal J; Mummudi N; Noronha V; Prabhash K; Patil V; Purandare N; Janu A; Kaushal R; Kannan S
BMJ Open; 2021 Feb; 11(2):e041345. PubMed ID: 33589450
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
[TBL] [Abstract][Full Text] [Related]
12. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
13. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
14. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial.
Rai ZL; Ranieri V; Palmer DH; Littler P; Ghaneh P; Gurusamy K; Manas D; Pizzo E; Psarelli EE; Gilmore R; Peddu P; Bartlett DC; de Liguori Carino N; Davidson BR
BMJ Open; 2022 May; 12(5):e050166. PubMed ID: 35551086
[TBL] [Abstract][Full Text] [Related]
15. Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer.
Ciani O; Cucciniello M; Petracca F; Apolone G; Merlini G; Novello S; Pedrazzoli P; Zilembo N; Broglia C; Capelletto E; Garassino M; Nicod E; Tarricone R
BMJ Open; 2019 Feb; 9(2):e025483. PubMed ID: 30772862
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a digital lifestyle intervention on health-related QUAlity of life in non-small cell LUng CAncer survivors following inpatient rehabilitation: protocol of the QUALUCA Swiss multicentre randomised controlled trial.
Weber M; Raab AM; Schmitt KU; Büsching G; Marcin T; Spielmanns M; Puhan MA; Frei A
BMJ Open; 2024 Mar; 14(3):e081397. PubMed ID: 38453202
[TBL] [Abstract][Full Text] [Related]
17. Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial.
Kok PS; Forde PM; Hughes B; Sun Z; Brown C; Ramalingam S; Cook A; Lesterhuis WJ; Yip S; O'Byrne K; Pavlakis N; Brahmer J; Anagnostou V; Ford K; Fitzpatrick K; Bricker A; Cummins MM; Stockler M; Nowak AK;
BMJ Open; 2022 Jan; 12(1):e057663. PubMed ID: 35078853
[TBL] [Abstract][Full Text] [Related]
18. SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial.
Billingy NE; Tromp VNMF; Veldhuijzen E; Belderbos J; Aaronson NK; Feldman E; Hoek R; Bogaard HJ; Onwuteaka-Philipsen BD; van de Poll-Franse L; Hugtenburg JG; van den Hurk CJG; Becker-Commissaris A; Walraven I
BMJ Open; 2021 Sep; 11(9):e052494. PubMed ID: 34518276
[TBL] [Abstract][Full Text] [Related]
19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
